Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company has added 30 new customers in the western portion of the United States.

"Over the past several months, the hemodialysis concentrates supply chain has experienced meaningful disruption, particularly in the western United States," said Mark Strobeck, Ph.D., President and CEO of Rockwell Medical. "Historically, hemodialysis concentrates supplier options in the west have been extremely limited. To stabilize the supply chain and ensure uninterrupted access to life-sustaining treatments for vulnerable patients with end-stage kidney disease, Rockwell Medical moved quickly to ensure product availability by rapidly scaling production and expanding our logistics infrastructure to address vital customer demand. As a result, we are now serving customers across the continental United States with our reliable supply chain and high-quality hemodialysis products."

The Company's new customer base includes, but is not limited to, a large, integrated, non-profit healthcare system; a comprehensive chronic kidney disease and dialysis care organization serving patients throughout California; a community-based, non-profit acute care hospital; and an innovation-driven renal care center developing and delivering next-generation artificial kidney solutions. With its expanded distribution capabilities, Rockwell Medical is now a viable alternative supplier in the western United States and is able to more efficiently deliver hemodialysis concentrates products to its existing customers with facilities in that region.